Ontology highlight
ABSTRACT:
SUBMITTER: Matsuda T
PROVIDER: S-EPMC5601624 | biostudies-literature | 2017 Aug
REPOSITORIES: biostudies-literature
Matsuda Tatsuo T Kato Taigo T Kiyotani Kazuma K Tarhan Yunus Emre YE Saloura Vassiliki V Chung Suyoun S Ueda Koji K Nakamura Yusuke Y Park Jae-Hyun JH
Oncotarget 20170615 35
MELK play critical roles in human carcinogenesis through activation of cell proliferation, inhibition of apoptosis and maintenance of stemness. Therefore, MELK is a promising therapeutic target for a wide range of cancers. Although p21 is a well-known p53-downstream gene, we found that treatment with a potent MELK inhibitor, OTS167, could induce p21 protein expression in cancer cell lines harboring loss-of-function <i>TP53</i> mutations. We also confirmed that MELK knockdown by siRNA induced the ...[more]